OTP-01

· Ottimo Pharma Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OTP-01, covering 2026-04-16 to 2026-04-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing